Resumen de acción SPNE
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de SeaSpine Holdings Corporation
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$9.54 |
| 52 Week High | US$13.64 |
| 52 Week Low | US$5.48 |
| Beta | 1.3 |
| 1 Month Change | 34.56% |
| 3 Month Change | 73.14% |
| 1 Year Change | -24.59% |
| 3 Year Change | -36.57% |
| 5 Year Change | -6.65% |
| Change since IPO | -54.57% |
Noticias y actualizaciones recientes
Recent updates
SeaSpine Holdings (NASDAQ:SPNE) Has Debt But No Earnings; Should You Worry?
Sep 24
SeaSpine: Bottom Line Fundamentals Continue To Soften
Sep 22SeaSpine amends $30M credit facility
Jul 19SeaSpine: Lacks Equity Premium To Deliver Real Risk-Adjusted Return
Jul 08Is SeaSpine Holdings (NASDAQ:SPNE) Using Debt Sensibly?
Jun 07SeaSpine begins limited commercial launch of the waveform L 3d-printed interbody system
Jun 08It Looks Like The CEO Of SeaSpine Holdings Corporation (NASDAQ:SPNE) May Be Underpaid Compared To Peers
May 27SeaSpine EPS misses by $0.13, beats on revenue
May 03SeaSpine guides Q4 and FY2020 revenue below consensus
Jan 11SeaSpine Holdings: Waiting To See If It Can Straighten Up
Dec 22Did SeaSpine Holdings' (NASDAQ:SPNE) Share Price Deserve to Gain 61%?
Dec 07SeaSpine (SPNE) Investor Presentation - Slideshow
Nov 17SeaSpine EPS beats by $0.06, beats on revenue; updates Q4 revenue guidance
Nov 09Rentabilidad de los accionistas
| SPNE | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 14.3% | -0.3% | 0.3% |
| 1Y | -24.6% | -0.6% | 24.2% |
Rentabilidad vs. Industria: SPNE obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del -3.7%.
Rentabilidad vs. Mercado: SPNE obtuvo unos resultados inferiores a los del mercado US, que fue del 19.3% el año pasado.
Volatilidad de los precios
| SPNE volatility | |
|---|---|
| SPNE Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 7.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de SPNE ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SPNE (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2015 | 523 | Keith Valentine | www.seaspine.com |
Resumen de fundamentos de SeaSpine Holdings Corporation
| Estadísticas fundamentales de SPNE | |
|---|---|
| Capitalización bursátil | US$360.18m |
| Beneficios(TTM) | -US$64.84m |
| Ingresos (TTM) | US$229.75m |
1.6x
Ratio precio-ventas (PS)-5.6x
Ratio precio-beneficio (PE)¿Está SPNE sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SPNE | |
|---|---|
| Ingresos | US$229.75m |
| Coste de los ingresos | US$87.83m |
| Beneficio bruto | US$141.92m |
| Otros gastos | US$206.75m |
| Beneficios | -US$64.84m |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -1.72 |
| Margen bruto | 61.77% |
| Margen de beneficio neto | -28.22% |
| Ratio deuda/patrimonio | 9.4% |
¿Cómo se ha desempeñado SPNE a largo plazo?
Ver rendimiento histórico y comparativa